#news #biotech Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility .Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility
klahucik
Wed, 08/11/2021 – 12:48

from FierceBiotech: Biotech https://ift.tt/3fX2wES